Insiders · Profile

Heidbreder Christian

Chief Scientific Officer at Indivior Pharmaceuticals. Filing since 11 Jun 2026. CIK 0002014639

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jul 2026
Chief Scientific Officer
Sold on a plan
18,586
$764.63K
8.2%
11 Jun 2026
Chief Scientific Officer
Sold on a plan
18,586
$707.38K
7.5%
2 decisions on file.